Hedge Fund Manager Week Features Olympian Founder

Hedge Fund Manager Week Features Olympian Founder

HFMweek feature on Michael J. Levas and Asclepius Life Sciences Fund LPOlympian Capital Makets Consulting L.L.C founder, Michael J. Levas, was featured int the November 1st edition of HFMWeek (Hedge Fund Manager Week).

HFMWeek journalist, Scott Macdonald, reports “Olympian Group founder Michael Levas has co-founded a new biotech and healthcare hybrid fund firm.”

The article features how the fund will “take a “friendly” activist approach with certain business where it sees firms requiring advice”.  Moreover, Mr. Macdonald features how “the fund launched on 1 October with a capacity of $500m and is set to raise over $100m from early investors”.  The article highlights Mr. Levas’s other co-founders including “Variant Pharmaceuticals CEO Steve Glover and co-founder Steven Gerst, who has held senior roles with Olympian and the Hospital Corporation of America”.

To read, ‘Olympian Founder Launches Biotech/Healthcare Hybrid Fund ‘ on the Asclepius Life Sciences Fund, LP web site, click here.


| News

| Events

| Disclaimer

The information contained in this web site has been prepared solely for informational purposes and is not an offer to sell or purchase or a solicitation of an offer to sell or purchase any interests or shares in any of the entities advised by Olympian Capital Markets Consulting, L.L.C. Such offers are made only by way of a private offering memorandum delivered to qualified investors.

| Contact

641 Lexington Avenue, 15th Floor
New York, NY 10022
Phone: (212) 634-6442